An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 3, 2006, Pages 298-304

  Chang, Kiki ^a   Saxena, Kirti ^a   Howe, Meghan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Bipolar disorder; Depression; Lamotrigine; Trial

Indexed keywords

ARIPIPRAZOLE; ATOMOXETINE; CARBAMAZEPINE; LAMOTRIGINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

ADOLESCENT; AGGRESSION; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CHILD PSYCHIATRY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; MALE; MANIA; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; REMISSION; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SLEEP DISORDER; SWEATING; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT CHANGE;

ADOLESCENT; ANTIMANIC AGENTS; ANXIETY DISORDERS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CHILD; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; TRIAZINES;

EID: 33645105476     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000194566.86160.a3     Document Type: Article

References (30)

1. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV (2000), Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 10:185-192
2. Calabrese JR, Bowden CL, McElroy SL et al. (1999a), Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry 156:1019-1023
3. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999b), A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60:79-88
4. Calabrese JR, Kasper S, Johnson G et al. (2004), International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry 65:571-579
5. Carandang CG, Maxwell DJ, Robbins DR, Oesterheld JR (2003), Lamotrigine in adolescent mood disorders. J Am Acad Child Adolesc Psychiatry 42:750-751
6. Chang K, Simeonova D (2004), Mood stabilizers: use in pediatric psychopharmacology. In: Handbook of Mental Health Interventions in Children and Adolescents: An Integrated Developmental Approach, Wilson J, ed. New York: Jossey-Bass, pp 363-412
7. Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT (2004), Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 14:372-394
8. Cicero D, El-Mallakh RS, Holman J, Robertson J (2003), Antidepressant exposure in bipolar children. Psychiatry 66:317-322
9. Coccaro EF, Harvey PD, Kupsaw LE, Herbert JL, Bernstein DP (2000), Overt Aggression Scale Modified [OAS M]. In: American Psychiatric Association Task Force for the Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association, pp 699-702
10. Craney J, Geller B (2003), Clinical implications of antidepressant and stimulant use on switching from depression to mania in children. J Child Adolesc Psychopharmacol 13:201-204
11. Emslie G, Judge R (2000), Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatr Scand Suppl 403:26-34
12. Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB (2004), Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord 82:149-158
13. Findling RL, Gracious BL, McNamara NK et al. (2001), Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord 3:202-210
14. Findling RL, McNamara NK, Gracious BL et al. (2003), Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895-901
15. Frazier JA, Biederman J, Tohen M et al. (2001), A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11:239-250
16. Geller B, Tillman R, Craney JL, Bolhofner K (2004), Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry 61:459-467
17. Geller B, Zimerman B, Williams M et al. (2000), Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157-164
18. Geller BG, Williams M, Zimerman B, Frazier J (1996), WASH-U-KSADS (Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia). St. Louis: Washington University
19. Ghaemi SN, Hsu DJ, Soldani F, Goodwill FK (2003), Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 5:421-433
20. Goodwin GM, Bowden CL, Calabrese JR et al. (2004), A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432-441
21. Guberman AH, Besag FM, Brodie MJ et al. (1999), Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 40:985-991
22. Ketter TA, Wang PW, Chandler RA et al. (2005), Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash. J Clin Psychiatry 66:642-645
23. Ketter TA, Wang PW, Nowakowska C, Marsh WK (2004), New medication treatment options for bipolar disorders. Acta Psychiatr Scand Suppl: 18-33
24. Kowatch RA, Suppes T, Carmody TJ et al. (2000), Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39:713-720
25. Kusumakar V, Yatham LN (1997), An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 72:145-148
26. Messenheimer J (2002), Efficacy and safety of lamotrigine in pediatric patients. J Child Neurol 17(suppl 2):2S34-2S42
27. Poznanski EO, Freeman LN, Mokros HB (1985), Children's Depression Rating Scale-Revised. Psychopharmacol Bull 21:979-989
28. Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R (1984), Preliminary studies of the reliability and validity of the children's depression rating scale. J Am Acad Child Psychiatry 23:191-197
29. Tillman R, Geller B (2003), Definitions of rapid, ultrarapid, and ultradian cycling and of episode duration in pediatric and adult bipolar disorders: a proposal to distinguish episodes from cycles. J Child Adolesc Psychopharmacol 13:267-271
30. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978), A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435